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Multiple endocrine neoplasia type 1 (MEN1) is
typically associated with adrenocorticotropic
hormone (ACTH)-dependent Cushing’s. However
this case illustrates a rare association between
MEN1 and adrenergic Cushing’s.
Case report
A 35-year-old man presented to his general prac-
titioner with hypertension in February 2006.
During routine investigations he was noted to
have mildly deranged liver function [ALT 59 IU/
L (8–40 IU/L), GGT 178 IU/L (10–50 IU/L)] and
an ultrasound scan showed mild fatty inﬁltration
and bilateral renal calculi. He was referred to the
urology department for investigation of renal
stones and a CT intravenous urogram showed
multiple renal calculi and a 6×5×5 cm soft tissue
enhancing lesion within the right adrenal gland
and a 7 mm calciﬁed density within the body of
the pancreas (Figure 1). He was therefore referred
to our endocrinology department for further diag-
nostic work-up.
On examination he had centripetal obesity,
gynaecomastia and facial plethora. His initial
blood tests revealed elevated calcium of
3.03 mmol/L (2.1–2.5 mmol/L) associated with
an elevated PTH of 27.5 pmol/L (1.5–7 pmol/L).
Baseline pituitary proﬁle revealed raised prolactin
of 1143 mU/L (80–400 mU/L) with normal
thyroid and sex hormone levels. MRI scan of the
pituitary demonstrated a focal 7 mm
non-enhancing abnormality seen in the left side
of the pituitary gland in keeping with a small
microadenoma (Figure 2). An overnight dexa-
methasone suppression test and low dose dexa-
methasone suppression tests were both positive,
with suppressed basal ACTH (Table 1). His
24-hour catecholamine excretion, renin-aldoster-
one ratio and fasting gut hormone proﬁle were
normal.
The above investigations led usto conclude that
he had adrenal Cushing’s associated with primary
hyperparathyroidism and a pituitary micro-
adenoma. His adrenal Cushing’s was treated ﬁrst
in July 2008 by laparoscopic adrenalectomy con-
ﬁrming a glucocorticoid adenoma. His sesta Mibi
parathyroid scan revealed increased uptake in the
left inferior position suggestive of parathyroid
adenoma, but there was also delayed uptake in
the other three parathyroid glands. He therefore
had a four gland parathyroidectomy in December
2008 which conﬁrmed parathyroid hyperplasia.
The combination of parathyroid hyperplasia
and pituitary microadenoma was suggestive of
MEN Type 1. This was conﬁrmed by genotype
testing which showed the presence of a C to T
nucleotide substitution of exon 4 of MEN 1
(c.781C > T). He has been referred on to the
regional MEN clinic for family screening.
Discussion
Multiple endocrine neoplasia (MEN1) is charac-
terized by the presence of tumours related to
two or more endocrine glands in the same
patient. MEN1 usually involves the parathyroids
(95%), pancreas (40%) or the pituitary (29%)
1 but
occasionally other endocrine glands are involved
as well. The underlying genetic basis is the homo-
zygous inactivation of the tumour suppressive
menin gene on chromosome 11q13.
2 MEN1 is an
autosomal dominant genetic disorder but up to
10% of patients have de novo mutations.
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CASE REPORT
1Glucocorticoid excess in MEN1 is usually
caused by ACTH-secreting pituitary adenomas.
In contrast Cushing’s syndrome due to adrenocor-
tical adenomas/carcinomas is very rare with a few
case reports in the medical literature.
3 The preva-
lence of adrenal lesions in patients with MEN1
varies from 36% to 73% in various case series.
4,5
This is in contrast to the general population
where 5–10% have adrenal lesions.
6 The adrenal
lesions in MEN1 vary from nodular hyperplasia
to adenomas and cysts (and very rarely
carcinomas).
7 However these lesions are often
incidental ﬁndings and are predominantly non-
functional.
5 In MEN1 patients with adrenal
lesions pancreatic tumours tended to be over-
represented implying a polyclonal adrenal pro-
liferation related to pancreatic tumour genesis.
5
The Menin gene has an important role in cell
growth and mutations in this gene lead to the
loss of this tumour suppressive property. This is
likely to increase the growth of different
tumours. Indeed Bhuiyan et al. have demonstrated
the upregulated expression of MEN1 mRNA and
menin protein in adrenocortical adenomas and
carcinomasthat are associated with MEN1
7 imply-
ing that the Menin gene is likely to have a role in
the pathogenesis of these tumours.
Conclusion
This case report discusses a patient with a rare
combination of MEN1 and a glucocorticoid
Figure 1
CT scan of the abdomen demonstrating an adrenal adenoma
Table 1
Results of dynamic endocrine tests
Test Cortisol
value
(nmol/L)
ACTH
value
(ng/L)
Midnight cortisol 152 <5
Overnight dexamethasone
suppression test
181 –
Low dose dexamethasone
suppression test
Basal 289
48 hours
184
<5
High dose dexamethasone
suppression test
Basal 316
48 hours
221
Both midnight and post suppression cortisol
values in normal subjects are 50 nmol/L
Figure 2
MRI of the pituitary demonstrating a pituitary adenoma
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2secreting adrenal adenoma. The clinical impli-
cation of this is that clinicians looking after
patients with Cushing’s syndrome need to be
aware of the possibility of MEN1 as an underlying
cause and furthermore in patients with MEN1
there should be a high degree of clinical suspicion
regarding the possibility of various endocrinopa-
thies that are not in the standard list for MEN1.
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